Two Sigma Advisers LP acquired a new position in shares of iKang Healthcare Group Inc (NASDAQ:KANG) during the 4th quarter, HoldingsChannel.com reports. The firm acquired 26,200 shares of the medical research company’s stock, valued at approximately $414,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. BlackRock Inc. increased its holdings in iKang Healthcare Group by 5.8% during the 4th quarter. BlackRock Inc. now owns 801,734 shares of the medical research company’s stock worth $12,669,000 after purchasing an additional 43,981 shares during the period. Kontiki Capital Management HK Ltd. purchased a new position in iKang Healthcare Group during the 4th quarter worth $5,276,000. State of Wisconsin Investment Board increased its holdings in iKang Healthcare Group by 643.5% during the 4th quarter. State of Wisconsin Investment Board now owns 148,700 shares of the medical research company’s stock worth $2,349,000 after purchasing an additional 128,700 shares during the period. California Public Employees Retirement System increased its holdings in iKang Healthcare Group by 39.5% during the 4th quarter. California Public Employees Retirement System now owns 91,931 shares of the medical research company’s stock worth $1,453,000 after purchasing an additional 26,031 shares during the period. Finally, SG Americas Securities LLC increased its holdings in iKang Healthcare Group by 48.7% during the 4th quarter. SG Americas Securities LLC now owns 67,573 shares of the medical research company’s stock worth $1,068,000 after purchasing an additional 22,139 shares during the period. Institutional investors own 33.50% of the company’s stock.

KANG opened at $20.01 on Friday. The firm has a market cap of $1,381.90, a price-to-earnings ratio of 76.54 and a beta of 0.07. iKang Healthcare Group Inc has a 52 week low of $11.70 and a 52 week high of $20.14. The company has a current ratio of 0.76, a quick ratio of 0.74 and a debt-to-equity ratio of 0.03.

iKang Healthcare Group (NASDAQ:KANG) last released its quarterly earnings data on Thursday, March 22nd. The medical research company reported $0.40 EPS for the quarter. The company had revenue of $206.39 million for the quarter. iKang Healthcare Group had a return on equity of 4.97% and a net margin of 3.16%.

Several research firms have commented on KANG. ValuEngine upgraded iKang Healthcare Group from a “sell” rating to a “hold” rating in a report on Monday, April 2nd. BidaskClub upgraded iKang Healthcare Group from a “buy” rating to a “strong-buy” rating in a report on Tuesday, March 27th.

COPYRIGHT VIOLATION WARNING: “Two Sigma Advisers LP Invests $414,000 in iKang Healthcare Group Inc (KANG) Stock” was published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this story on another site, it was illegally copied and republished in violation of U.S. & international trademark and copyright legislation. The correct version of this story can be viewed at https://www.thecerbatgem.com/2018/04/22/two-sigma-advisers-lp-invests-414000-in-ikang-healthcare-group-inc-kang-stock.html.

iKang Healthcare Group Profile

iKang Healthcare Group, Inc, together with its subsidiaries, provides preventive healthcare solutions in the People's Republic of China. The company operates in two segments, Medical Examinations and Other Medical Services, and Dental Services. It offers a range of medical examinations, including internal, gynecology, ophthalmology, ENT, dental, lab tests, electrocardiogram, ultrasound, and X-ray examination items.

Want to see what other hedge funds are holding KANG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iKang Healthcare Group Inc (NASDAQ:KANG).

Institutional Ownership by Quarter for iKang Healthcare Group (NASDAQ:KANG)

Receive News & Ratings for iKang Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iKang Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.